Close Menu

NEW YORK – Integrated DNA Technologies, a Danaher company, has been authorized by the US Food and Drug Administration to provide reagents for diagnostic testing for the SARS-CoV-2 virus. The authorization has been granted under the Centers for Disease Control and Prevention's existing emergency use authorization.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.